DAIO:NASDAQData I/O Corporation Analysis
Data as of 2026-06-14 - not real-time
$4.03
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
The stock is trading at $4.03, just below the 52‑week high of $4.49, with the 20‑day SMA (3.63) comfortably above both the 50‑day and 200‑day SMAs, suggesting a short‑term bullish bias. However, the RSI sits at 66 — near the overbought zone – and the MACD histogram has turned negative, signaling bearish momentum, while volume has been on a decline and 30‑day volatility exceeds 100%, indicating a choppy market.
Fundamentally, DAIO posted a 47% plunge in revenue and a loss of $0.34 per share, far missing consensus estimates. Gross margins remain respectable at ~48%, but operating margins are deeply negative (‑96%), and the company reports a trailing EPS of –$0.86 with a forward EPS of only $0.06. The balance sheet is relatively clean, with $5.7 M in cash versus $1.2 M of debt, but earnings are weak and ROE is –57%.
Analysts project a target price of $5.00, implying roughly a 24% upside from current levels. The upside is driven primarily by a announced transformational acquisition that could double the company’s size, but the near‑term catalyst is the recent earnings miss and bearish technical signals, creating a mixed outlook.
Fundamentally, DAIO posted a 47% plunge in revenue and a loss of $0.34 per share, far missing consensus estimates. Gross margins remain respectable at ~48%, but operating margins are deeply negative (‑96%), and the company reports a trailing EPS of –$0.86 with a forward EPS of only $0.06. The balance sheet is relatively clean, with $5.7 M in cash versus $1.2 M of debt, but earnings are weak and ROE is –57%.
Analysts project a target price of $5.00, implying roughly a 24% upside from current levels. The upside is driven primarily by a announced transformational acquisition that could double the company’s size, but the near‑term catalyst is the recent earnings miss and bearish technical signals, creating a mixed outlook.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- Quarterly earnings miss and widening loss
- Bearish MACD crossover and decreasing volume
- Price approaching resistance with limited upside
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Transformational acquisition expected to boost scale
- Forward EPS improvement and modest cash cushion
- Target price suggests ~24% upside despite current volatility
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- Potential market expansion in IoT, automotive and edge AI segments
- Low debt level and adequate cash reserves
- Long‑term upside tied to successful integration of the acquisition
Key Metrics & Analysis
Financial Health
Revenue Growth-47.40%
Profit Margin-43.20%
P/E Ratio67.2
ROE-57.30%
ROA-23.39%
Debt/Equity11.80
P/B Ratio3.6
Industry P/E36.8
Technical Analysis
TrendNeutral
RSI65.9
Support$2.76
Resistance$4.49
MA 20$3.63
MA 50$3.00
MA 200$3.00
MACDBearish
VolumeDecreasing
Fear & Greed Index89.86
Valuation
Target Price$5.00
Upside/Downside24.07%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta0.84
Volatility100.74%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.